Cinacalcet and cardiovascular mortality in hemodialysis patients

被引：0
|
作者：
Klein, Gordon L. [1 ]
机构：
[1] Shriners Burns Hosp, Galveston, TX 77550 USA
来源：
KIDNEY INTERNATIONAL | 2010年 / 78卷 / 08期
关键词：
CALCIUM-SENSING RECEPTOR;
D O I：
10.1038/ki.2010.299
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：820 / 820
页数：1
相关论文
共 50 条
  • [1] Cinacalcet therapy and cardiovascular risk in hemodialysis patients
    Zelaznicka, Marzena
    Kocelak, Piotr
    Glinianowicz, Magdalena Olszanecka
    Chudek, Jerzy
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2012, 66 : 722 - 729
  • [2] THE CARDIOVASCULAR EFFECTS OF CINACALCET IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM
    Choi, Bum Soon
    Choi, Sun Ryoung
    Park, Hoon Suk
    Hong, Yu Ah
    Chung, Byung Ha
    Kim, Young Soo
    Yang, Chul Woo
    Kim, Yong-Soo
    Park, Cheol Whee
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 442 - 442
  • [3] Hyperuricemia and cardiovascular mortality in patients on hemodialysis
    Nature Reviews Nephrology, 2011, 7 (11) : 606 - 606
  • [4] Hypocalcemia and cardiovascular mortality in cinacalcet users
    Goto, Shunsuke
    Hamano, Takayuki
    Fujii, Hideki
    Taniguchi, Masatomo
    Abe, Masanori
    Nitta, Kosaku
    Nishi, Shinichi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 (04) : 637 - 647
  • [5] The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial
    Parfrey, Patrick S.
    Drueeke, Tilman B.
    Block, Geoffrey A.
    Correa-Rotter, Ricardo
    Floege, Juergen
    Herzog, Charles A.
    London, Gerard M.
    Mahaffey, Kenneth W.
    Moe, Sharon M.
    Wheeler, David C.
    Kubo, Yumi
    Dehmel, Bastian
    Goodman, William G.
    Chertow, Glenn M.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 10 (05): : 791 - 799
  • [6] Effects of Cinacalcet on Atherosclerotic and Nonatherosclerotic Cardiovascular Events in Patients Receiving Hemodialysis: The EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) Trial
    Wheeler, David C.
    London, Gerard M.
    Parfrey, Patrick S.
    Block, Geoffrey A.
    Correa-Rotter, Ricardo
    Dehmel, Bastian
    Drueeke, Tilman B.
    Floege, Juergen
    Kubo, Yumi
    Mahaffey, Kenneth W.
    Goodman, William G.
    Moe, Sharon M.
    Trotman, Marie-Louise
    Abdalla, Safa
    Chertow, Glenn M.
    Herzog, Charles A.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2014, 3 (06):
  • [7] Lipoprotein(a) is a predictor for cardiovascular mortality of hemodialysis patients
    Koda, Y
    Nishi, S
    Suzuki, M
    Hirasawa, Y
    KIDNEY INTERNATIONAL, 1999, 56 : S251 - S253
  • [8] Association of adipokine with cardiovascular mortality in patients on hemodialysis
    Kumada, Y.
    Ishii, H.
    Takahashi, H.
    Aoyama, T.
    Kamoi, D.
    Shibata, R.
    Tanaka, M.
    Murohara, T.
    EUROPEAN HEART JOURNAL, 2012, 33 : 606 - 606
  • [9] Osteoprotegerin and mortality in hemodialysis patients with cardiovascular disease
    Winther, Simon
    Christensen, Jeppe Hagstrup
    Flyvbjerg, Allan
    Schmidt, Erik Berg
    Jorgensen, Kaj Anker
    Skou-Jorgensen, Hanne
    Svensson, My
    CLINICAL NEPHROLOGY, 2013, 80 (03) : 161 - 167
  • [10] PULSE PRESSURE: A PREDICTOR OF CARDIOVASCULAR CALCIFICATION AND CARDIOVASCULAR MORTALITY IN HEMODIALYSIS PATIENTS
    Rroji , Merita
    Seferi, Saimir
    Cafka, Majlinda
    Likaj, Erjola
    Cadri, Vilma
    Barbullushi, Myftar
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
12345